Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-19: Addition of Azithromycin to Chloroquine Treatment
2020-001527-14Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in coronavirus disease 2019 (COVID-19) comparing Chloroquine alone with Chloroquine + azithromycin (2 arms). Primary endpoint: Clinical cure at day 7 during admission. Started Apr 2020; status: active.
02
Drugs
chloroquineazithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001527-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001527-14.